Clinical Trial Update: Open-Label Study of ARD-0403 in Testosterone Deficient Men [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial of ARD-0403 in men with testosterone deficiency (hypogonadism) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• ARD-0403 (ARD-0403)

Snippet

Sponsor: Ardana Bioscience Ltd | Conditions: Hypogonadism | Phase 3 | Status: TERMINATED